Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MJNA that's huge
Go $MJNA
$USMJ nice news on USMJ
Go $USMJ
$USMJ USMJ DIVIDEND UPDATE - PURA STOCK ANTICIPATED FROM JULY 2015 TRANSACTION ON HORIZON – VIEW ONLINE PRESENTATION
Source: InvestorsHub NewsWire
North American Cannabis Holdings, Inc. CEO Highlights Puration’s Rapid Progress In Online Presentation
Puration, Inc. Presents: Cannabis Extracts; Current Sales; EVERx Sports and Fitness; Colorado Lab; Chinese Hemp Farm; Compliance and Dividends
DALLAS, TX – February 9, 2015
North American Cannabis Holdings, Inc. (USMJ) today announced an online presentation released by Puration, Inc. (PURA) and available now on the Company’s website:
PURATION ONLINE UPDATE PRESENTATION
Puration, Inc. entered the emerging cannabis sector last July when it acquired the health and wellness operations of North American Cannabis Holdings, Inc. in a transaction to include an issuance of Puration common stock to shareholders of North American Cannabis Holdings. The presentation available on the Company’s website covers new and updated information to include the following topics:
Current Sales of Puration Products
Cannabinoid Extraction Capacity
Extraction Lab in Colorado
Hemp Farm in China
Cannabis Extract Source for North American Cannabis Holdings EVERx
Cannabis Market Sector Horizon Beyond North American Cannabis
North American Cannabis Holding’s CEO Commentary on Rapid Rate of Puration Developments
Compliance and Dividend Issue Update
Upcoming Analyst Coverage
Learn more about Puration, Inc. and keep up to date on the rapid changes anticipated throughout 2016 on the Company’s website: http://www.purationinc.com/
North American Cannabis Holdings, Inc. maintains ongoing analyst coverage. The independent analyst recently upgraded the ongoing analyst coverage to a ‘buy recommendation’ with an increased PPS target. The full report is available at the link below:
USMJ ‘BUY RECOMMENDATION’ AND INCREASED PPS TARGET
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit http://www.growusmj.com.
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com
$USMJ USMJ DIVIDEND UPDATE - PURA STOCK ANTICIPATED FROM JULY 2015 TRANSACTION ON HORIZON – VIEW ONLINE PRESENTATION
Source: InvestorsHub NewsWire
North American Cannabis Holdings, Inc. CEO Highlights Puration’s Rapid Progress In Online Presentation
Puration, Inc. Presents: Cannabis Extracts; Current Sales; EVERx Sports and Fitness; Colorado Lab; Chinese Hemp Farm; Compliance and Dividends
DALLAS, TX – February 9, 2015
North American Cannabis Holdings, Inc. (USMJ) today announced an online presentation released by Puration, Inc. (PURA) and available now on the Company’s website:
PURATION ONLINE UPDATE PRESENTATION
Puration, Inc. entered the emerging cannabis sector last July when it acquired the health and wellness operations of North American Cannabis Holdings, Inc. in a transaction to include an issuance of Puration common stock to shareholders of North American Cannabis Holdings. The presentation available on the Company’s website covers new and updated information to include the following topics:
Current Sales of Puration Products
Cannabinoid Extraction Capacity
Extraction Lab in Colorado
Hemp Farm in China
Cannabis Extract Source for North American Cannabis Holdings EVERx
Cannabis Market Sector Horizon Beyond North American Cannabis
North American Cannabis Holding’s CEO Commentary on Rapid Rate of Puration Developments
Compliance and Dividend Issue Update
Upcoming Analyst Coverage
Learn more about Puration, Inc. and keep up to date on the rapid changes anticipated throughout 2016 on the Company’s website: http://www.purationinc.com/
North American Cannabis Holdings, Inc. maintains ongoing analyst coverage. The independent analyst recently upgraded the ongoing analyst coverage to a ‘buy recommendation’ with an increased PPS target. The full report is available at the link below:
USMJ ‘BUY RECOMMENDATION’ AND INCREASED PPS TARGET
About North American Cannabis Holdings, Inc.
North American Cannabis Holdings, Inc. (USMJ) is founded on the core belief that cannabis makes people's lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. For more information please visit http://www.growusmj.com.
Follow the company on Twitter: http://twitter.com/US_HEMP.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
CONTACT:
Steven Rash
Phone: +1-972-528-0162
Email: Info@growusmj.com
$PMCB ~ PharmaCyte Biotech, Inc. due diligence report
$PMCB recent news/filings
## source: finance.yahoo.com
Mon, 08 Feb 2016 14:00:00 GMT ~ Johnson & Johnson and Big Pharma Could Find a Diabetes "Cure" With PharmaCyte Biotech's Type 1 Diabetes Treatment
[Marketwired] - Johnson & Johnson , like much of the biopharmaceutical industry worldwide, is aware of the desperate necessity for a Type 1 diabetes treatment. In fact, Diego Miralles, J&J's head of global innovation, ...
read full: http://finance.yahoo.com/news/johnson-johnson-big-pharma-could-140000750.html
*********************************************************
Tue, 02 Feb 2016 12:30:00 GMT ~ Where are the Traders Headed - Analyst Notes on CD International Enterprises, Valley High Mining, Pharmacyte Biotech and Bombardier
[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 2, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: CD International ...
read full: http://finance.yahoo.com/news/where-traders-headed-analyst-notes-123000207.html
*********************************************************
Mon, 01 Feb 2016 14:05:00 GMT ~ Trading Ahead of Upcoming Developments -- New Research on Trans-Pacific Aerospace Company, Pharmacyte Biotech, First Mining Finance, and Accretive Health
[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Trans-Pacific ...
read full: http://finance.yahoo.com/news/trading-ahead-upcoming-developments-research-140500683.html
*********************************************************
Thu, 28 Jan 2016 12:43:00 GMT ~ Presidential Elections Put Cannabis & Cannabis Stocks To Watch, Center Stage In 2016
[Accesswire] - CORAL GABLES, FL / ACCESSWIRE / January 28, 2016 / There's no debating the wild ride the marijuana industry has had since legalization for recreational use went live in 2014. Now two years later we are ...
read full: http://finance.yahoo.com/news/presidential-elections-put-cannabis-cannabis-124300853.html
*********************************************************
Mon, 25 Jan 2016 17:47:09 GMT ~ PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial
[at noodls] - SILVER SPRING, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) - PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its ...
read full: http://www.publicnow.com/view/28F42A22A64DD4473B7669A8E686AE2F2A16F544
*********************************************************
$PMCB charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$PMCB company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/PMCB/company-info
Ticker: $PMCB
OTC Market Place: OTCQB
CIK code: 0001157075
Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com
Incorporated In: NV, USA
Business Description: PharmaCyte Biotech is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as \"Cell-in-a-Box\" This unique and patented technology will be used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer and its symptoms, and diabetes are being developed. PharmaCyte Biotech's treatment for solid tumor cancers involves encapsulating modified live cells capable of converting the prodrug ifosfamide into its active or \"cancer-killing\" form. These encapsulated live cells are placed as close to the tumor as possible to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer. Ifosfamide is then given intravenously at one third the normal dose to eliminate adverse side effects. When the ifosfamide comes in contact with the encapsulated live cells through the circulatory system, the activation of the drug takes place at or near the tumor. This \"targeted chemotherapy\" has proven remarkably effective and safe to use in past clinical trials. PharmaCyte Biotech is also developing treatments for cancer based upon chemical constituents of the Cannabis plant. It is examining ways to exploit the benefits of Cell-in-a-Box technology in optimizing the anticancer effectiveness of Cannabis, while minimizing or outright eliminating the debilitating side effects usually associated with cancer treatments. In addition to developing treatments for pancreatic and other cancers, PharmaCyte Biotech is developing a treatment for Type 1 diabetes and Type 2 insulin-dependent diabetes. PharmaCyte Biotech plans to encapsulate a human cell line which has been genetically engineered to produce, store and secrete insulin on demand at levels in proportion to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology.Less >>
$PMCB share structure
## source: otcmarkets.com
Market Value: $51,807,051 a/o Feb 08, 2016
Shares Outstanding: 750,826,823 a/o Dec 10, 2015
Float: 529,206,849 a/o Aug 26, 2014
Authorized Shares: 1,490,000,000 a/o Aug 26, 2014
Par Value: 0.0001
$PMCB extra dd links
Company name: PharmaCyte Biotech, Inc.
Company website: http://http://www.PharmaCyte.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=PMCB+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=PMCB+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=PMCB+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/news - http://finance.yahoo.com/q/h?s=PMCB+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/PMCB/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=PMCB+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/PMCB
DTCC (dtcc.com): http://search2.dtcc.com/?q=PharmaCyte+Biotech%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=PharmaCyte+Biotech%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=PharmaCyte+Biotech%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://http://www.PharmaCyte.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://http://www.PharmaCyte.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://http://www.PharmaCyte.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/PMCB
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001157075&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=PMCB&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=PMCB
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=PMCB+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=PMCB+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=PMCB
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=PMCB
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=PMCB+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/PMCB/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=PMCB+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/PMCB.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=PMCB
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/PMCB/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/PMCB/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/PMCB
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/PMCB
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/PMCB:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=PMCB
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=PMCB